EDITORIAL
Published on 16 Sep 2022
Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
doi 10.3389/fonc.2022.997404
- 1,597 views
- 1 citation
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Beyond Chemotherapy and Immunotherapy in Thoracic Malignancies: Overcoming Resistance by Tackling New Molecular Pathways
Beyond Chemotherapy and Immunotherapy in Thoracic Malignancies: Overcoming Resistance by Tackling New Molecular Pathways
12k
Total downloads
42k
Total views and downloads
Articles
REVIEW
Published on 20 Apr 2022
The Landscape of Immunotherapy Resistance in NSCLC
doi 10.3389/fonc.2022.817548
- 14,100 views
- 42 citations
ORIGINAL RESEARCH
Published on 08 Mar 2022
The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer
doi 10.3389/fonc.2022.722646
- 2,251 views
- 11 citations
REVIEW
Published on 09 Feb 2022
Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
doi 10.3389/fonc.2022.769124
- 4,642 views
- 27 citations
ORIGINAL RESEARCH
Published on 31 Jan 2022
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
doi 10.3389/fonc.2022.772076
- 2,001 views
- 12 citations
ORIGINAL RESEARCH
Published on 23 Dec 2021
A Retrospective Analysis of the Effect of Anlotinib in Patients With Lung Cancer With or Without Previous Antiangiogenic Therapy
doi 10.3389/fonc.2021.788837
- 1,340 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Oct 2021
SPTBN2, a New Biomarker of Lung Adenocarcinoma
doi 10.3389/fonc.2021.754290
- 3,344 views
- 13 citations
CLINICAL TRIAL
Published on 08 Sep 2021
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
doi 10.3389/fonc.2021.728155
- 4,091 views
- 15 citations
ORIGINAL RESEARCH
Published on 06 Sep 2021
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma
doi 10.3389/fonc.2021.734873
- 1,931 views
- 5 citations
